• Heptamethine Cyanine Dye CA800-PR Suppresses PR in HR+ Breas

  2026-07-29

  A novel heptamethine cyanine dye, CA800-PR, selectively targets hormone receptor-positive breast cancer by suppressing progesterone receptor activity and inducing Golgi fragmentation. This strategy bypasses estrogen receptor pathways and may offer an alternative to conventional hormone therapies, with implications for tumor apoptosis and immune modulation.

• Streptavidin-Cy3: Fluorescent Biotin Detection & Workflow Ma

  2026-07-29

  Streptavidin-Cy3 from APExBIO empowers researchers with ultra-bright, stable biotin detection across immunohistochemistry, immunofluorescence, and flow cytometry. This article delivers actionable protocols, troubleshooting strategies, and direct insights from pioneering microrobotics research—bridging high-sensitivity detection with next-generation experimental demands.

• AZD0156: ATM Kinase Inhibitor Workflows for Cancer Research

  2026-07-28

  AZD0156 is transforming DNA damage response studies by providing highly selective ATM kinase inhibition, enabling researchers to dissect DNA repair and metabolic adaptation mechanisms in cancer. With optimized protocols and troubleshooting strategies, this potent inhibitor from APExBIO empowers robust, reproducible results in both standalone and combination assays.

• Perifosine (KRX-0401): Reliable Akt Inhibition for Apoptosis

  2026-07-28

  This article addresses the core challenges biomedical researchers face when using Perifosine (SKU A8309) in apoptosis, viability, and radiosensitization assays. It delivers scenario-driven, evidence-backed guidance for optimizing workflows and ensuring reproducibility, with actionable links to APExBIO’s validated Perifosine resource.

• Phosbind Acrylamide: Precision Phosphate-Binding Reagent for

  2026-07-27

  Phos binding reagent (Phosbind) acrylamide delivers selective, antibody-free detection of phosphorylated proteins during SDS-PAGE. This phosphate-binding reagent enables analysis of protein phosphorylation states in the 30–130 kDa range at physiological pH. Its robust solubility and workflow compatibility make it a key tool in protein phosphorylation analysis.

• FGFR1 Identified as a Druggable Target in Schizophrenia Ther

  2026-07-27

  A recent Molecular Neurobiology study leverages integrated genetic and molecular analyses to identify FGFR1 as a promising druggable gene for schizophrenia. This approach highlights new therapeutic avenues, supporting the development of targeted interventions beyond current antipsychotic paradigms.

• Chloroquine (BA1002): Technical Guide for Research Workflows

  2026-07-26

  Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) addresses key research needs as an autophagy inhibitor, anti-inflammatory agent for malaria research, and rheumatoid arthritis research compound. This guide covers practical workflow parameters, troubleshooting, and scope boundaries to ensure reliable laboratory implementation. Not suitable for water-based assays or unmonitored clinical translation.

• Isochlorogenic Acid A Disrupts HBV via HO-1-Mediated ROS Mod

  2026-07-25

  This study elucidates how isochlorogenic acid A (ICAA) impairs hepatitis B virus (HBV) replication by upregulating heme oxygenase-1 (HO-1) and altering intracellular reactive oxygen species (ROS) levels. The findings reveal ICAA disrupts multiple HBV life cycle stages, including viral morphogenesis and cccDNA maintenance, suggesting new directions for metabolic disease and antiviral research.

• Tomivosertib: MNK1 Inhibitor Workflows for Translational Res

  2026-07-24

  Tomivosertib enables highly selective modulation of the MNK-eIF4E pathway, unlocking precise control over metabolic and oncogenic signaling in disease models. This guide distills experimental best practices, protocol enhancements, and troubleshooting insights to maximize Tomivosertib’s value in both metabolic and cancer research.

• MRT68921: Advanced ULK1 Kinase Inhibitor Workflows in Autoph

  2026-07-24

  MRT68921 stands out as a nanomolar-selective ULK1 kinase inhibitor, enabling precise disruption of autophagy for high-resolution pathway interrogation. This article details robust protocol enhancements, troubleshooting insights, and direct translation of recent lipid autophagy research—empowering next-generation metabolic and cell signaling studies.

• NHS-Biotin: Precision Biotinylation for Protein Engineering

  2026-07-23

  NHS-Biotin, a membrane-permeable amine-reactive reagent from APExBIO, enables high-fidelity biotinylation of antibodies and proteins, streamlining workflows in advanced protein detection and purification. Its robust amide bond formation and compatibility with intracellular labeling make it a cornerstone for next-generation biochemical and protein engineering applications.

• GS-441524 Prodrug Pathways: Mechanistic Insights & Translati

  2026-07-23

  This thought-leadership article explores the latest mechanistic insights and translational strategies surrounding GS-441524 and its prodrug derivatives in antiviral research. Integrating advanced LC–MS/MS mapping, pharmacokinetic profiling, and practical protocol guidance, it illuminates how researchers can leverage high-purity GS-441524 from APExBIO to accelerate the development of next-generation anti-SARS-CoV-2 nucleoside analogs.

• Tomivosertib: Advanced MNK1 Inhibitor Workflows for AML & Be

  2026-07-22

  Tomivosertib stands out as a highly selective MNK1/2 inhibitor, enabling precise modulation of the MNK-eIF4E signaling pathway in cancer and metabolic research. Its robust performance in both cellular and in vivo models empowers translational studies from leukemia to neurobiology, with actionable troubleshooting and protocol insights for accelerated results.

• Phosbind Acrylamide: Precision Phosphate-Binding Reagent for

  2026-07-22

  Phosbind Acrylamide is a high-solubility phosphate-binding reagent that enables precise, antibody-free detection of protein phosphorylation states via SDS-PAGE. Its selective interaction with phosphate groups allows researchers to distinguish phosphorylated from non-phosphorylated proteins within the 30–130 kDa range. The reagent supports robust, reproducible phosphorylation analysis workflows with clear performance benchmarks.

• Schlafen-11/9 as Intracellular ssDNA Sensors in Innate Immun

  2026-07-21

  The referenced study uncovers Schlafen-11 (SLFN11) and Schlafen-9 (SLFN9) as cytosolic receptors that specifically detect intracellular single-stranded DNA (ssDNA) containing CGT motifs, triggering cytokine expression and lytic cell death. This discovery redefines our understanding of innate immune sensing and provides new molecular targets for investigating inflammation and disease states associated with aberrant ssDNA.

16512 records 1/1101 page Next 12345 下5页 Last page